Direkt zum Inhalt
Merck
  • Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum.

Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum.

Antimicrobial agents and chemotherapy (2005-09-29)
P Holzmuller, D Sereno, J-L Lemesre
ZUSAMMENFASSUNG

We previously documented the induction of Leishmania amastigote apoptosis by trivalent antimony (SbIII) and nitric oxide (NO). We demonstrate here that SbIII-resistant amastigotes were resistant to NO toxicity when delivered extracellularly by NO donors or intracellularly via macrophage activation. Shared biochemical targets for SbIII and NO resistance in Leishmania are discussed.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Kaliumantimonyltartrat Trihydrat, ACS reagent, ≥99%
Sigma-Aldrich
Kaliumantimonyltartrat Trihydrat, puriss., meets analytical specification of USP, 99.0-103.0%, powder
Sigma-Aldrich
Kaliumantimonyltartrat Trihydrat, purum p.a., 99.0-103% (RT)